Gary V. Burton

Adjuvant chemotherapy and timing of tamoxifen in postmenopausal patients with endocrine-responsive, node-positive breast cancer: a phase 3, open-label, randomised controlled trial

Kathy S. Albain, William E. Barlow, Peter M. Ravdin et al. · The Lancet · 2009 · 257 citations · Full text

Node-positive Breast Cancer, Breast Oncology, Oncology +9

SWOG S0221: A Phase III Trial Comparing Chemotherapy Schedules in High-Risk Early-Stage Breast Cancer

G. Thomas Budd, William E. Barlow, Halle C. F. Moore et al. · Journal of Clinical Oncology · 2014 · 119 citations · Full text

Randomized, Multicenter, Placebo-Controlled Clinical Trial of Duloxetine Versus Placebo for Aromatase Inhibitor–Associated Arthralgias in Early-Stage Breast Cancer: SWOG S1202

N. Lynn Henry, Joseph M. Unger, Anne F. Schott et al. · Journal of Clinical Oncology · 2017 · 112 citations · Full text

Pain Therapy, Pain Disorders, Breast Oncology +22

Prevalence of Hepatitis B Virus, Hepatitis C Virus, and HIV Infection Among Patients With Newly Diagnosed Cancer From Academic and Community Oncology Practices

Scott D. Ramsey, Joseph M. Unger, Laurence H. Baker et al. · JAMA Oncology · 2019 · 87 citations · Full text

Phase III Trial of Carmustine and Cisplatin Compared With Carmustine Alone and Standard Radiation Therapy or Accelerated Radiation Therapy in Patients With Glioblastoma Multiforme: North Central Cancer Treatment Group 93-72-52 and Southwest Oncology Group 9503 Trials

Jan C. Buckner, Karla V. Ballman, John C. Michalak et al. · Journal of Clinical Oncology · 2006 · 86 citations · Full text